DJIA 17,712.66 34.43 0.19%
NASDAQ 4,891.22 27.86 0.57%
S&P 500 2,061.02 4.87 0.24%
market minute promo

347.46 6.65 (1.95%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

IBB $347.46 1.95%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $341.98
Previous Close $340.81
Daily Range $341.64 - $349.44
52-Week Range $207.48 - $374.97
Market Cap $8.1B
P/E Ratio -1,481.78
Dividend (Yield) $0.22 (0.2%)
Ex-Dividend Date
Dividend Pay Date
Volume 1,973,840
Average Daily Volume 1,721,343
Current FY EPS $0.00




Financial Services

iShares NASDAQ Biotechnology Index (ETF) (IBB) Description

The investment seeks investment results that correspond generally to the price and yield performance before fees and expenses of the NASDAQ Biotechnology Index (the underlying index). Website:

News & Commentary Rss Feed

Is Gilead Sciences Inc. About to Crater Before Our Very Eyes?

Gilead Sciences has become a battleground stock due to the uncertainty surrounding the future of the hep C market. Here is a look at why the bears might be right in their assessment of this top biotech stock.

The 'End Game' - My Take On Indicators Leading To The End Of The U.S. Bull Market

Best And Worst ETFs Of The Week Amid Slowing Corporate Profits

Best And Worst ETFs Of The Week Amid Slowing Corporate Profits

A Bold Call On Biotech ETFs

Why Investors Might Want To Stay Away From The Biotech ETF

A Buyback Or Biotech Bubble?

Jim Cramer -- There's No Bubble in Biotech or Semiconductor Sectors

Pharmacyclics, BioMarin, And Incyte: A Quick Screen

Markets Recover From Yemen Turmoil, Biotech Pain

Today's financial recap and tomorrow's financial outlook.

See More IBB News...

IBB's Top Competitors

IBB $347.46 (1.95%)
Current stock: IBB
VTA $12.01 (-0.17%)
Current stock: VTA
NCV $9.07 (0.22%)
Current stock: NCV
ZTR $13.63 (0.17%)
Current stock: ZTR